Name: ferric chloride-induced arterial thrombosis and sample collection for 3d electron microscopy analysis
Uploaded: 2023-03-17T13:45:00
Description: Watch this Scientific Journal Video about Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis at JoVE.com

The authors thank the members of the Whiteheart Laboratory for their careful perusal of this manuscript. The work was supported by grants from the NIH, NHLBI (HL56652, HL138179, and HL150818), and a Department of Veterans Affairs Merit Award to S.W.W., R01 HL 155519 to B.S., and NIBIB intramural program grant to R.D.L.

All experiments discussed here were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Kentucky.
NOTE: Surgical instruments are listed in Figure 1 and the Table of Materials. C57BL/6J mice, 8-10 weeks old, male/female or relevant genetically manipulated (Knockout or Knockin) strains were used.
1. FeCl3-induced carotid artery injury
<ol>
	<l...

<ol>
	<li>Lozano, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Global+and+regional+mortality+from+235+causes+of+death+for+20+age+groups+in+1990+and+2010:+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2010.">Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.</a> Lancet. 380 (9859), 2095-2128 (2012).</li><li>Raskob, G. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Thrombosis:+a+major+contributor+to+global+disease+burden.">Thrombosis: a major contributor to global disease burden.</a> Arteriosclerosis, Thrombosis, and Vascular Biology. 34 (11), 2363-2371 (2014).</li><li>Walton, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lead+aspartate,+an+en+bloc+contrast+stain+particularly+useful+for+ultrastructural+enzymology.">Lead aspartate, an en bloc contrast stain particularly useful for ultrastructural enzymology.</a> Journal of Histochemistry and Cytochemistry. 27 (10), 1337-1342 (1979).</li><li>Palta, S., Saroa, R., Palta, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Overview+of+the+coagulation+system.">Overview of the coagulation system.</a> Indian Journal of Anaesthesia. 58 (5), 515-523 (2014).</li><li>Joshi, S., Whiteheart, S. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+nuts+and+bolts+of+the+platelet+release+reaction.">The nuts and bolts of the platelet release reaction.</a> Platelets. 28 (2), 129-137 (2017).</li><li>Periayah, M. H., Halim, A. S., Mat Saad, A. Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanism+action+of+platelets+and+crucial+blood+coagulation+pathways+in+hemostasis.">Mechanism action of platelets and crucial blood coagulation pathways in hemostasis.</a> International Journal of Hematology-Oncology and Stem Cell Research. 11 (4), 319-327 (2017).</li><li>Alexopoulos, D., Katogiannis, K., Sfantou, D., Lekakis, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Combination+antiplatelet+treatment+in+coronary+artery+disease+patients:+A+necessary+evil+or+an+overzealous+practice.">Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice.</a> Platelets. 29 (3), 228-237 (2018).</li><li>Kurz, K. D., Main, B. W., Sandusky, G. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rat+model+of+arterial+thrombosis+induced+by+ferric+chloride.">Rat model of arterial thrombosis induced by ferric chloride.</a> Thrombosis Research. 60 (4), 269-280 (1990).</li><li>Denis, C. V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Towards+standardization+of+in+vivo+thrombosis+studies+in+mice.">Towards standardization of in vivo thrombosis studies in mice.</a> Journal of Thrombosis and Haemostasis. 9 (8), 1641-1644 (2011).</li><li>Marsh Lyle, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assessment+of+thrombin+inhibitor+efficacy+in+a+novel+rabbit+model+of+simultaneous+arterial+and+venous+thrombosis.">Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis.</a> Thrombosis and Haemostasis. 79 (3), 656-662 (1998).</li><li>Kato, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inhibition+of+arterial+thrombosis+by+a+protease-activated+receptor+1+antagonist,+FR171113,+in+the+guinea+pig.">Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig.</a> European Journal of Pharmacology. 473 (2-3), 163-169 (2003).</li><li>Huttinger, A. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ferric+chloride-induced+canine+carotid+artery+thrombosis:+a+large+animal+model+of+vascular+injury.">Ferric chloride-induced canine carotid artery thrombosis: a large animal model of vascular injury.</a> Journal of Visualized Experiments. (139), e57981 (2018).</li><li>Zhang, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antithrombotic+therapy+by+regulating+the+ROS-mediated+thrombosis+microenvironment+and+specific+nonpharmaceutical+thrombolysis+Using+Prussian+blue+nanodroplets.">Antithrombotic therapy by regulating the ROS-mediated thrombosis microenvironment and specific nonpharmaceutical thrombolysis Using Prussian blue nanodroplets.</a> Small. 18 (15), 2106252 (2022).</li><li>Liu, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Platelet+membrane+cloaked+nanotubes+to+accelerate+thrombolysis+by+thrombus+clot-targeting+and+penetration.">Platelet membrane cloaked nanotubes to accelerate thrombolysis by thrombus clot-targeting and penetration.</a> Small. , 2205260 (2022).</li><li>Refaat, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Near-infrared+light-responsive+liposomes+for+protein+delivery:+Towards+bleeding-free+photothermally-assisted+thrombolysis.">Near-infrared light-responsive liposomes for protein delivery: Towards bleeding-free photothermally-assisted thrombolysis.</a> Journal of Controlled Release. 337, 212-223 (2021).</li><li>Li, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biomimetic+nanoplatelets+to+target+delivery+hirudin+for+site-specific+photothermal/photodynamic+thrombolysis+and+preventing+venous+thrombus+formation.">Biomimetic nanoplatelets to target delivery hirudin for site-specific photothermal/photodynamic thrombolysis and preventing venous thrombus formation.</a> Small. 18 (51), 2203184 (2022).</li><li>Subramaniam, S., Kanse, S. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ferric+chloride-induced+arterial+thrombosis+in+mice.">Ferric chloride-induced arterial thrombosis in mice.</a> Current Protocols in Mouse Biology. 4 (4), 151-164 (2014).</li><li>Cocchiaro, J. L., Kumar, Y., Fischer, E. R., Hackstadt, T., Valdivia, R. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cytoplasmic+lipid+droplets+are+translocated+into+the+lumen+of+the+Chlamydia+trachomatis+parasitophorous+vacuole.">Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole.</a> Proceedings of the National Academy of Sciences. 105 (27), 9379-9384 (2008).</li><li>Kaplan, E. L., Meier, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nonparametric-estimation+from+incomplete+observations.">Nonparametric-estimation from incomplete observations.</a> Journal of the American Statistical Association. 53 (282), 457-481 (1958).</li><li>Chauhan, A. K., Kisucka, J., Lamb, C. B., Bergmeier, W., Wagner, D. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=von+Willebrand+factor+and+factor+VIII+are+independently+required+to+form+stable+occlusive+thrombi+in+injured+veins.">von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.</a> Blood. 109 (6), 2424-2429 (2007).</li><li>Andre, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CD40L+stabilizes+arterial+thrombi+by+a+beta3+integrin--dependent+mechanism.">CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism.</a> Nature Medicine. 8 (3), 247-252 (2002).</li><li>Ni, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Persistence+of+platelet+thrombus+formation+in+arterioles+of+mice+lacking+both+von+Willebrand+factor+and+fibrinogen.">Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.</a> Journal of Clinical Investigation. 106 (3), 385-392 (2000).</li><li>Bergmeier, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+role+of+platelet+adhesion+receptor+GPIbalpha+far+exceeds+that+of+its+main+ligand,+von+Willebrand+factor,+in+arterial+thrombosis.">The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.</a> Proceedings of the National Academy of Sciences. 103 (45), 16900-16905 (2006).</li><li>Ciciliano, J. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Resolving+the+multifaceted+mechanisms+of+the+ferric+chloride+thrombosis+model+using+an+interdisciplinary+microfluidic+approach.">Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach.</a> Blood. 126 (6), 817-824 (2015).</li><li>Eckly, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+underlying+FeCl3-induced+arterial+thrombosis.">Mechanisms underlying FeCl3-induced arterial thrombosis.</a> Journal of Thrombosis and Haemostasis. 9 (4), 779-789 (2011).</li><li>Woollard, K. J., Sturgeon, S., Chin-Dusting, J. P. F., Salem, H. H., Jackson, S. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Erythrocyte+hemolysis+and+hemoglobin+oxidation+promote+ferric+chloride-induced+vascular+injury.">Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.</a> Journal of Biological Chemistry. 284 (19), 13110-13118 (2009).</li><li>Shim, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+ferric+chloride-induced+arterial+thrombosis+model+of+mice+and+the+role+of+red+blood+cells+in+thrombosis+acceleration.">Characterization of ferric chloride-induced arterial thrombosis model of mice and the role of red blood cells in thrombosis acceleration.</a> Yonsei Medical Journal. 62 (11), 1032-1041 (2021).</li><li>Ghosh, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+of+the+prothrombotic+potential+of+four-factor+prothrombin+complex+concentrate+(4F-PCC)+in+animal+models.">Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models.</a> PLoS One. 16 (10), 0258192 (2021).</li><li>Wilbs, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cyclic+peptide+FXII+inhibitor+provides+safe+anticoagulation+in+a+thrombosis+model+and+in+artificial+lungs.">Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs.</a> Nature Communications. 11 (1), 3890 (2020).</li><li>Wei, Y., Deng, X., Sheng, G., Guo, X. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+rabbit+model+of+cerebral+venous+sinus+thrombosis+established+by+ferric+chloride+and+thrombin+injection.">A rabbit model of cerebral venous sinus thrombosis established by ferric chloride and thrombin injection.</a> Neuroscience Letters. 662, 205-212 (2018).</li><li>Jacob-Ferreira, A. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antithrombotic+activity+of+Batroxase,+a+metalloprotease+from+Bothrops+atrox+venom,+in+a+model+of+venous+thrombosis.">Antithrombotic activity of Batroxase, a metalloprotease from Bothrops atrox venom, in a model of venous thrombosis.</a> International Journal of Biological Macromolecules. 95, 263-267 (2017).</li><li>Zhou, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+rabbit+model+of+cerebral+microembolic+signals+for+translational+research:+preclinical+validation+for+aspirin+and+clopidogrel.">A rabbit model of cerebral microembolic signals for translational research: preclinical validation for aspirin and clopidogrel.</a> Journal of Thrombosis and Haemostasis. 14 (9), 1855-1866 (2016).</li><li>Yang, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+evodiamine+on+collagen-induced+platelet+activation+and+thrombosis.">Effect of evodiamine on collagen-induced platelet activation and thrombosis.</a> BioMed Research International. 2022, 4893859 (2022).</li><li>Li, W., McIntyre, T. M., Silverstein, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ferric+chloride-induced+murine+carotid+arterial+injury:+A+model+of+redox+pathology.">Ferric chloride-induced murine carotid arterial injury: A model of redox pathology.</a> Redox Biology. 1 (1), 50-55 (2013).</li><li>Li, W., Nieman, M., Sen Gupta, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ferric+chloride-induced+murine+thrombosis+models.">Ferric chloride-induced murine thrombosis models.</a> Journal of Visualized Experiments. (115), e54479 (2016).</li><li>Holly, S. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ether+lipid+metabolism+by+AADACL1+regulates+platelet+function+and+thrombosis.">Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis.</a> Blood Advances. 3 (22), 3818-3828 (2019).</li><li>Bird, J. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prediction+of+the+therapeutic+index+of+marketed+anti-coagulants+and+anti-platelet+agents+by+guinea+pig+models+of+thrombosis+and+hemostasis.">Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.</a> Thrombosis Research. 123 (1), 146-158 (2008).</li></ol>

The topical application of FeCl3 to the vasculature to induce thrombosis is a widely used technique, and has been instrumental in establishing roles for various platelet receptors, ligand signaling pathways, and their inhibitors20,21,22,23. The mechanism through which FeCl3 causes thrombosis is multifaceted; previously, endothelial denudation was considered a cause of thro...

Thrombosis is the formation of a blood clot that partially or completely blocks a blood vessel, impeding the natural flow of the blood. This leads to severe and fatal cardiovascular events, such as ischemic heart disease and strokes. Cardiovascular diseases are the leading cause of morbidity and mortality, and cause one in four deaths worldwide1,2,3. Although thrombosis is manifested as a malfunction of the vascular system, it could be a result of an underlying microbial or viral infection, immune disorder, malignancy, or metabolic condition. The flow of blood is maintained by the complex interaction among diverse components of the vascular system, including endothelial cells, red/white blood cells, platelets, and coagulation factors4. Upon vascular injury, platelets interact with adhesive proteins on the subendothelial matrix and release their granular contents, which recruit more platelets5. Concurrently, the coagulation cascade is activated, leading to fibrin formation and deposition. Ultimately, a clot is formed, containing platelets and red blood cells trapped within a fibrin mesh6. Although antiplatelet and anticoagulant drugs are available to modulate thrombosis, spurious bleeding remains a major concern with these therapies, requiring fine-tuning of the dosages and combinations of these drugs. Thus, there is still an urgent need to discover new anti-thrombotic drugs7.
Thrombosis is studied using multiple methods to inflict vascular injury: mechanical (vessel ligation), thermal (laser injury), and chemical injury (FeCl3/Rose Bengal application). The nature of thrombosis varies depending on the location (arterial vs. venous), method, or extent of the injury. Among all these types, FeCl3-induced vascular injury is the most widely used method. It has been employed in mice, rats, rabbits, guinea pigs, and dogs8,9,10,11,12. The method is relatively simple, easy to use, and if major parameters are standardized, it is sensitive and reproducible in various vascular systems (e.g., arteries [carotid and femoral], veins [jugular], and arterioles [cremaster and mesenteric]) (Supplemental Table 1).
This model can also be used to further our understanding of the mechanics and morphology of clot formation. This technique uniquely offers the advantage of stopping thrombosis at various flow rate points, to study the intermediate stages of the process before it becomes occlusive. Recent advances in thrombosis research have used this model to focus attention on non-pharmacological methods of thrombolysis13 or non-invasive delivery of anti-thrombotic and/or fibrinolytic agents14,15. Several groups have shown that, when platelet membranes are coated with these therapeutics, the drugs can be activated upon thermal stimulation to target clots16. The techniques described here can be useful to such studies as validation of their findings at the single platelet level. In this manuscript, Protocol 1 describes the basic FeCl3-mediated vascular injury procedure, while Protocol 2 describes the method to collect and fix the vascular injury sample for further analysis by electron microscopy.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>0.9% Saline&#160;</td>
			<td>Fisher Scientific&#160;</td>
			<td>BP358-212</td>
			<td>NaCl used to make a solution of 0.9% saline&#160;</td>
		</tr>
		<tr>
			<td>1 mL Syringe&#160;</td>
			<td>Becton, Dickinson and Company&#160;</td>
			<td>309659</td>
			<td></td>
		</tr>
		<tr>
			<td>190 Proof Ethanol&#160;</td>
			<td>KOPTEC</td>
			<td>V1101&#160;</td>
			<td>Used to make a 70% ethanol solution to use for prepping the mouse for surgery&#160;</td>
		</tr>
		<tr>
			<td>2,2,2 Tribromoethanol</td>
			<td>Sigma Aldrich</td>
			<td>48402</td>
			<td></td>
		</tr>
		<tr>
			<td>25 Yard Black Braided Silk Suture (5-0)</td>
			<td>DEKNATEL</td>
			<td>136082-1204</td>
			<td></td>
		</tr>
		<tr>
			<td>26G x 3/8 Needle&#160;</td>
			<td>Becton, Dickinson and Company&#160;</td>
			<td>305110</td>
			<td></td>
		</tr>
		<tr>
			<td>2-methyl-2-butanol</td>
			<td>Sigma Aldrich</td>
			<td>240486</td>
			<td></td>
		</tr>
		<tr>
			<td>7.5 mL Transfer Pipet, Graduated to 3 mL</td>
			<td>Globe Scientific Inc.</td>
			<td>135010</td>
			<td></td>
		</tr>
		<tr>
			<td>Alcohol Prep Pads (70% Isopropyl Alcohol)</td>
			<td>Medline</td>
			<td>MDS090735</td>
			<td></td>
		</tr>
		<tr>
			<td>Araldite GY 502&#160;</td>
			<td>Electron microscopy Services&#160;</td>
			<td>10900</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell Culture Dish 35mm X 10mm&#160;</td>
			<td>Corning Incorporated&#160;</td>
			<td>430165</td>
			<td></td>
		</tr>
		<tr>
			<td>Compact Scale&#160;</td>
			<td>Ward&#39;s Science&#160;</td>
			<td>470314-390</td>
			<td></td>
		</tr>
		<tr>
			<td>Dissecting Scissors, 12.5 cm long</td>
			<td>World Precision Instrument</td>
			<td>15922-G</td>
			<td></td>
		</tr>
		<tr>
			<td>DMP-30 activator&#160;</td>
			<td>Electron microscopy Services&#160;</td>
			<td>13600</td>
			<td></td>
		</tr>
		<tr>
			<td>Dodenyl Succinic Anhydride/ DDSA</td>
			<td>Electron microscopy Services&#160;</td>
			<td>13700</td>
			<td></td>
		</tr>
		<tr>
			<td>Doggy Poo Bags/animal carcass disposal bag</td>
			<td>Crown Products&#160;</td>
			<td>PP-RB-200</td>
			<td></td>
		</tr>
		<tr>
			<td>Doppler FlowProbe</td>
			<td>Transonic Systems Inc.</td>
			<td>MA0.5PSB</td>
			<td></td>
		</tr>
		<tr>
			<td>EMBED 812 resin&#160;</td>
			<td>Electron microscopy Services&#160;</td>
			<td>14900</td>
			<td></td>
		</tr>
		<tr>
			<td>Ethyl Alcohol, anhydrous 200 proof&#160;</td>
			<td>Electron microscopy Services&#160;</td>
			<td>15055</td>
			<td></td>
		</tr>
		<tr>
			<td>Eye Dressing Forceps, 4&#34; Full Curved, Standard, 0.8mm Wide Tips</td>
			<td>Integra Miltex</td>
			<td>18-784</td>
			<td></td>
		</tr>
		<tr>
			<td>Filter Paper&#160;</td>
			<td>VWR</td>
			<td>28310-106</td>
			<td></td>
		</tr>
		<tr>
			<td>Fine Scissors - Sharp-Blunt</td>
			<td>Fine Science Tools&#160;</td>
			<td>14028-10</td>
			<td></td>
		</tr>
		<tr>
			<td>Finger Loop Ear Punches&#160;</td>
			<td>Fine Science Tools&#160;</td>
			<td>24212-01</td>
			<td></td>
		</tr>
		<tr>
			<td>Gauze Sponges 2&#8221; x 2&#8221; &#8211; 12 Ply&#160;</td>
			<td>Dukal Corporation</td>
			<td>2128</td>
			<td></td>
		</tr>
		<tr>
			<td>Glutaraldehyde (10% solution)</td>
			<td>Electron microscopy Services&#160;</td>
			<td>16120</td>
			<td></td>
		</tr>
		<tr>
			<td>Integra Miltex Carbon Steel Surgical Blade #10</td>
			<td>Integra&#174; Miltex&#174;</td>
			<td>4110</td>
			<td></td>
		</tr>
		<tr>
			<td>Iron (III) Chloride&#160;</td>
			<td>SIGMA-ALDRICH</td>
			<td>157740-100G</td>
			<td></td>
		</tr>
		<tr>
			<td>Knife Handle Miltex&#174; Extra Fine Stainless Steel Size 3</td>
			<td>Integra Lifesciences&#160;</td>
			<td>157510</td>
			<td></td>
		</tr>
		<tr>
			<td>L-aspartic acid</td>
			<td>Sigma&#160;Fisher</td>
			<td>&#160;A93100</td>
			<td></td>
		</tr>
		<tr>
			<td>L-aspartic acid</td>
			<td>Fisher Scientific&#160;</td>
			<td>BP374-100</td>
			<td></td>
		</tr>
		<tr>
			<td>Lead Nitrate&#160;</td>
			<td>Fisher Scientific&#160;</td>
			<td>L-62</td>
			<td></td>
		</tr>
		<tr>
			<td>LEICA S8AP0 Microscope</td>
			<td>LEICA</td>
			<td>No longer available</td>
			<td>No longer available from the company</td>
		</tr>
		<tr>
			<td>LEICA S8AP0 Microscope Stand&#160;</td>
			<td>LEICA</td>
			<td>10447255</td>
			<td>No longer available from the company</td>
		</tr>
		<tr>
			<td>Light-Duty Tissue Wipers&#160;</td>
			<td>VWR</td>
			<td>82003-822</td>
			<td></td>
		</tr>
		<tr>
			<td>Micro Dissecting Forceps; 1x2 Teeth, Full Curve; 0.8 mm Tip Width; 4&#34; Length</td>
			<td>Roboz Surgical Instrument Company</td>
			<td>RS-5157</td>
			<td></td>
		</tr>
		<tr>
			<td>Osmium Tetroxide 4% aqueous solution&#160;</td>
			<td>Electron microscopy Services&#160;</td>
			<td>19150</td>
			<td></td>
		</tr>
		<tr>
			<td>Paraformaldehyde (16% solution)</td>
			<td>Electron microscopy Services&#160;</td>
			<td>15710</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium ferricyanide</td>
			<td>SIGMA-ALDRICH</td>
			<td>P-8131</td>
			<td></td>
		</tr>
		<tr>
			<td>Propylene Oxide, ACS reagent&#160;</td>
			<td>Electron microscopy Services&#160;</td>
			<td>20401</td>
			<td></td>
		</tr>
		<tr>
			<td>Rainin Classic Pipette PR-10</td>
			<td>Rainin</td>
			<td>17008649</td>
			<td></td>
		</tr>
		<tr>
			<td>Research Flowmeter&#160;</td>
			<td>Transonic Systems Inc.</td>
			<td>T402B01481</td>
			<td>Model: T402</td>
		</tr>
		<tr>
			<td>Scotch Magic Invisible Tape, 3/4&#34; x 1000&#34;, Clear</td>
			<td>Scotch&#160;</td>
			<td>305289</td>
			<td></td>
		</tr>
		<tr>
			<td>Small Animal Heated Pad</td>
			<td>K&#38;H Manufacturing Inc.</td>
			<td>Model: HM10</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium Cacodylate Buffer 0.2M, pH7.4</td>
			<td>Electron microscopy Services&#160;</td>
			<td>11623</td>
			<td></td>
		</tr>
		<tr>
			<td>Sterile Cotton Tipped Applicators&#160;</td>
			<td>Puritan Medical Products&#160;</td>
			<td>25-806 1WC</td>
			<td></td>
		</tr>
		<tr>
			<td>Steromaster Illuminator&#160;</td>
			<td>Fisher Scientific&#160;</td>
			<td>12-562-21</td>
			<td>No longer available from the company</td>
		</tr>
		<tr>
			<td>Surgical Dumont #7 Forceps&#160;</td>
			<td>Fine Science Tools&#160;</td>
			<td>11271-30</td>
			<td></td>
		</tr>
		<tr>
			<td>Thiocarbohydrazide (TCH)</td>
			<td>SIGMA-ALDRICH</td>
			<td>88535</td>
			<td></td>
		</tr>
		<tr>
			<td>Universal Low Retention Pipet Tip Reloads (0.1-10 &#181;L)</td>
			<td>VWR</td>
			<td>76323-394</td>
			<td></td>
		</tr>
		<tr>
			<td>Uranyl Acetate</td>
			<td>Electron microscopy Services&#160;</td>
			<td>22400</td>
			<td></td>
		</tr>
		<tr>
			<td>Veet Gel Cream Hair Remover</td>
			<td>Reckitt Benckiser</td>
			<td>3116875</td>
			<td></td>
		</tr>
		<tr>
			<td>White Antistatic Hexagonal Weigh Boats, Medium, 64 x 15 x 19 mm</td>
			<td>Fisher Scientific&#160;</td>
			<td>S38975</td>
			<td></td>
		</tr>
		<tr>
			<td>WinDAQ/100 Software for Windows</td>
			<td>DATAQ Instruments, Inc.</td>
			<td>Version 3.38</td>
			<td>Freely available to download. https://www.dataq.com/products/windaq/</td>
		</tr>
		<tr>
			<td>ZEISS AxioCam Icc 1</td>
			<td>ZEISS</td>
			<td>57615</td>
			<td></td>
		</tr>
	</tbody>
</table>

ferric chloride-induced arterial thrombosis and sample collection for 3d electron microscopy analysis

Cardiovascular diseases are a leading cause of mortality and morbidity worldwide. Aberrant thrombosis is a common feature of systemic conditions like diabetes and obesity, and chronic inflammatory diseases like atherosclerosis, cancer, and autoimmune diseases. Upon vascular injury, usually the coagulation system, platelets, and endothelium act in an orchestrated manner to prevent bleeding by forming a clot at the site of the injury. Abnormalities in this process lead to either excessive bleeding or uncontrolled thrombosis/insufficient antithrombotic activity, which translates into vessel occlusion and its sequelae. The FeCl3-induced carotid injury model is a valuable tool in probing how thrombosis initiates and progresses in vivo. This model involves endothelial damage/denudation and subsequent clot formation at the injured site. It provides a highly sensitive, quantitative assay to monitor vascular damage and clot formation in response to different degrees of vascular damage. Once optimized, this standard technique can be used to study the molecular mechanisms underlying thrombosis, as well as the ultrastructural changes in platelets in a growing thrombus. This assay is also useful to study the efficacy of antithrombotic and antiplatelet agents. This article explains how to initiate and monitor FeCl3-induced arterial thrombosis and how to collect samples for analysis by electron microscopy.

The data are generally presented as time to occlusion, or time required to form a fully occlusive thrombus. These data can be plotted as a Kaplan-Meier survival curve (Figure 4A)19, a dot plot with bars showing the terminal blood flow at the time of either cessation of the blood flow or the termination of an experiment (Figure 4B), or as a line graph (Figure 4C). Thrombus stability can be studied using this t...

Watch this Scientific Journal Video about Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis at JoVE.com

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

The present protocol describes how to use a FeCl3-mediated injury to induce arterial thrombosis, and how to collect and prepare arterial injury samples at various stages of thrombosis for electron microscopy analysis.

Cardiovascular diseases are a leading cause of mortality and morbidity worldwide. Aberrant thrombosis is a common feature of systemic conditions like ...

With this method, one can determine what components of platelets and the hemostatic system are important for thrombosis. Additionally, this method can determine how thrombus growth and architecture are affected at the cellular level. The main advantage of this technique is that it allows a reproducible way to study many stages of thrombosis on a structural level.A person new to this technique should avoid over-handling the tissue in the surgical area. This can lead to bleeding and can overcomplicate the identification of the carotid artery. Begin marking the injury site after exposing the carotid artery by loosely encircling the region between two surgical threads having a 0.1 millimeter size.Place the probe under the artery distal from the lower thread. Insert the plastic piece under the artery between the two threads to mark the site for iron chloride injury. Take flow measurements before performing injury to note the basal flow.Perform the injury by placing iron chloride-soaked filter paper on the artery for three minutes. Remove the filter paper after three minutes to prevent the variable extent of the injury and to facilitate flow counting by the probe. Add saline at the injury site to remove any excess residual iron chloride.Monitor the flow reading. When the flow drops below 50%of the initial value, remove the probe. Quickly dry the area and add the fixative to fix the injury area externally.Next, promptly hold the artery near the injury area with forceps. Cut downstream of the lower thread and upstream of the upper thread. Put the tissue on the plastic tissue culture dish in the same orientation as it was collected and add a few drops of the fixative.Using a scalpel, clean the extra tissue around the artery. Ensure recording the orientation of the blood flow by cutting one end horizontally and the other tapering or oblique. Place the sample in fixative for one hour at room temperature, then store the sample in 1%paraformaldehyde at 4 degrees Celsius until sending it down wet ice for electron microscopy analysis.The data was plotted as a Kaplan-Meier survival curve, a dot plot with bars showing the terminal blood flow at the time of either cessation of the blood flow or the termination of an experiment, or as a line graph. The blood flow increased suddenly in some cases following a gradual decrease for a few minutes indicating partial shedding of the growing thrombus and was considered an embolization event. Occlusive thrombus morphology was studied using this method as well.The prompt collection of the sample during the thrombosis process is the most important step since delay in this process may lead to misinterpretation of our structural analysis.

ferric-chloride-induced-arterial-thrombosis-sample-collection-for-3d

Research

JoVE Journal

Medicine

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Atherosclerosis is a disease of the large arteries and a major underlying cause of myocardial infarction and stroke. Several different mouse models have been developed to facilitate the study of the molecular and cellular pathophysiology of this disease. In this manuscript we describe specific techniques for the quantification and characterization of atherosclerotic lesions in the murine aortic sinus and ascending aorta. The advantage of this procedure is that it provides an accurate measurement of the cross-sectional area and total volume of the lesion, which can be used to compare atherosclerotic progression across different treatment groups. This is possible through the use of the valve leaflets as an anatomical landmark, together with careful adjustment of the sectioning angle. We also describe basic staining methods that can be used to begin to characterize atherosclerotic progression. These can be further modified to investigate antigens of specific interest to the researcher. The described techniques are generally applicable to a wide variety of existing and newly created dietary and genetically-induced models of atherogenesis.

We describe procedures to quantify and characterize atherosclerotic lesions in mouse models using precision sectioning of the aortic sinus and ascending aorta combined with histochemical and immunohistochemical analysis.

Atherosclerosis is a disease of the large arteries and a major underlying cause of myocardial infarction and stroke. Several different mouse models have ...

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Breast cancer growth can be studied in mice using a plethora of models. Genetic manipulation of breast cancer cells may provide insights into the functions of proteins involved in oncogenic progression or help to discover new tumor suppressors. In addition, injecting cancer cells into mice with different genotypes might provide a better understanding of the importance of the stromal compartment. Many models may be useful to investigate certain aspects of disease progression but do not recapitulate the entire cancerous process. In contrast, breast cancer cells engraftment to the mammary fat pad of mice better recapitulates the location of the disease and presence of the proper stromal compartment and therefore better mimics human cancerous disease. In this article, we describe how to implant breast cancer cells into mice orthotopically and explain how to collect tissues to analyse the tumor milieu and metastasis to distant organs. Using this model, many aspects (growth, angiogenesis, and metastasis) of cancer can be investigated simply by providing a proper environment for tumor cells to grow.

Cancer is a complex disease that is influenced by the tissue surrounding the tumor as well as local pro- and anti-inflammatory mediators. Therefore, orthotropic injection models, rather than subcutaneous models may be useful to study cancer progression in a manner that better mimics human pathology.

Breast cancer growth can be studied in mice using a plethora of models. Genetic manipulation of breast cancer cells may provide insights into the ...

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

We evaluated a magnetic resonance venography (MRV) approach with gadofosveset to quantify total thrombus volume changes as the principal criterion for treatment efficacy&#160;in a multicenter randomized study comparing edoxaban monotherapy with a heparin/warfarin regimen for acute, symptomatic lower extremities deep vein thrombosis (DVT) treatment. We also used a direct thrombus imaging approach (DTHI, without the use of a contrast agent) to quantify fresh thrombus. We then sought to evaluate the reproducibility of the analysis methodology and applicability of using 3D magnetic resonance venography and direct thrombus imaging for the quantification of DVT in a multicenter trial setting. From 10 randomly selected subjects participating in the edoxaban Thrombus Reduction Imaging Study (eTRIS), total thrombus volume in the entire lower extremity deep venous system was quantified bilaterally. Subjects were imaged using 3D-T1W gradient echo sequences before (direct thrombus imaging, DTHI) and 5 min after injection of 0.03 mmol/kg of gadofosveset trisodium (magnetic resonance venography, MRV). The margins of the DVT on corresponding axial, curved multi-planar reformatted images were manually delineated by two observers to obtain volumetric measurements of the venous thrombi. MRV was used to compute total DVT volume, whereas DTHI was used to compute volume of fresh thrombus. Intra-class correlation (ICC) and Bland Altman analysis were performed to compare inter and intra-observer variability of the analysis. The ICC for inter and intra-observer variability was excellent (0.99 and 0.98, p &#60;0.001, respectively) with no bias on Bland-Altman analysis for MRV images. For DTHI images, the results were slightly lower (ICC = 0.88 and 0.95 respectively, p &#60;0.001), with bias for inter-observer results on Bland-Altman plots. This study showed feasibility of thrombus volume estimation in DVT using MRV with gadofosveset trisodium, with good intra- and inter-observer reproducibility in a multicenter setting.

The goal of this study is to use magnetic resonance venography with long-circulating gadolinium-based contrast agent and direct thrombus imaging for quantitative evaluation of DVT volume in a multicenter, clinical trial setting. Inter- and intra-observer variability assessments were conducted, and reproducibility of the protocol was determined.

We evaluated a magnetic resonance venography (MRV) approach with gadofosveset to quantify total thrombus volume changes as the principal criterion for ...

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Severe thrombosis and its ischemic consequences such as myocardial infarction, pulmonary embolism and stroke are major worldwide health issues. The ferric chloride injury is now a well-established technique to rapidly and accurately induce the formation of thrombi in exposed veins or artery of small and large diameter. This model has played a key role in the study of the pathophysiology of thrombosis, in the discovery and validation of novel antithrombotic drugs and in the understanding of the mechanism of action of these new agents. Here, the implementation of this technique on a mesenteric vessel and carotid artery in mice is presented. The method describes how to label circulating leukocytes and platelets with a fluorescent dye and to observe, by intravital microscopy on the exposed mesentery, their accumulation at the injured vessel wall which leads to the formation of a thrombus. On the carotid artery, the occlusion caused by the clot formation is measured by monitoring the blood flow with a Doppler probe.

The FeCl3 induced thrombosis model in mice is described herein. A method to monitor thrombus growth by intravital microscopy observation on a mesenteric vessel and by blood flow measurement in the carotid artery is presented.

Severe thrombosis and its ischemic consequences such as myocardial infarction, pulmonary embolism and stroke are major worldwide health issues. The ferric ...

Ferric Chloride-induced Murine Thrombosis Models

Arterial thrombosis (blood clot) is a common complication of many systemic diseases associated with chronic inflammation, including atherosclerosis, diabetes, obesity, cancer and chronic autoimmune rheumatologic disorders. Thrombi are the cause of most heart attacks, strokes and extremity loss, making thrombosis an extremely important public health problem. Since these thrombi stem from inappropriate platelet activation and subsequent coagulation, targeting these systems therapeutically has important clinical significance for developing safer treatments. Due to the complexities of the hemostatic system, in vitro experiments cannot replicate the blood-to-vessel wall interactions; therefore, in vivo studies are critical to understand pathological mechanisms of thrombus formation. To this end, various thrombosis models have been developed in mice. Among them, ferric chloride (FeCl3) induced vascular injury is a widely used model of occlusive thrombosis that reports platelet activation and aggregation in the context of an aseptic closed vascular system. This model is based on redox-induced endothelial cell injury, which is simple and sensitive to both anticoagulant and anti-platelets drugs. The time required for the development of a thrombus that occludes blood flow gives a quantitative measure of vascular injury, platelet activation and aggregation that is relevant to thrombotic diseases. We have significantly refined this FeCl3-induced vascular thrombosis model, which makes the data highly reproducible with minimal variation. Here we describe the model and present representative data from several experimental set-ups that demonstrate the utility of this model in thrombosis research.

We report a refined procedure of the ferric chloride (FeCl3)-induced thrombosis models on carotid and mesenteric artery as well as vein, characterized efficiently using intravital microscopy to monitor time to occlusive thrombi formation.

Arterial thrombosis (blood clot) is a common complication of many systemic diseases associated with chronic inflammation, including atherosclerosis, ...

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Light-sheet fluorescence microscopy (LSFM), in combination with chemical clearing protocols, has become the gold standard for analyzing fluorescently labelled structures in large biological specimens, and is down to cellular resolution. Meanwhile, the constant refinement of underlying protocols and the enhanced availability of specialized commercial systems enable us to investigate the microstructure of whole mouse organs and even allow for the characterization of cellular behavior in various live-cell imaging approaches. Here, we describe a protocol for the spatial whole-mount visualization and quantification of the CD45+ leukocyte population in inflamed mouse hearts. The method employs a transgenic mouse strain (CD11c.DTR)that has recently been shown to serve as a robust, inducible model for the study of the development of fulminant fatal myocarditis, characterized by lethal cardiac arrhythmias. This protocol includes myocarditis induction, intravital antibody-mediated cell staining, organ preparation, and LSFM with subsequent computer-assisted image post-processing. Although presented as a highly-adapted method for our particular scientific question, the protocol represents the blueprint of an easily adjustable system that can also target completely different fluorescent structures in other organs and even in other species.

Here, we describe a light-sheet microscopy approach to visualize the cardiac CD45+ leukocyte infiltrate in a murine model of aseptic fulminant myocarditis, which is induced by the intratracheal diphtheria toxin treatment of CD11c.DTR mice.

Light-sheet fluorescence microscopy (LSFM), in combination with chemical clearing protocols, has become the gold standard for analyzing fluorescently ...

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells

To date, the available surgical and pharmacological treatments for cardiovascular diseases (CVD) are limited and often palliative. At the same time, gene and cell therapies are highly promising alternative approaches for CVD treatment. However, the broad clinical application of gene therapy is greatly limited by the lack of suitable gene delivery systems. The development of appropriate gene delivery vectors can provide a solution to current challenges in cell therapy. In particular, existing drawbacks, such as limited efficiency and low cell retention in the injured organ, could be overcome by appropriate cell engineering (i.e., genetic) prior to transplantation. The presented protocol describes the efficient and safe transient modification of endothelial cells using a polyethyleneimine superparamagnetic magnetic nanoparticle (PEI/MNP)-based delivery vector. Also, the algorithm and methods for cell characterization are defined. The successful intracellular delivery of microRNA (miR) into human umbilical vein endothelial cells (HUVECs) has been achieved without affecting cell viability, functionality, or intercellular communication. Moreover, this approach was proven to cause a strong functional effect in introduced exogenous miR. Importantly, the application of this MNP-based vector ensures cell magnetization, with accompanying possibilities of magnetic targeting and non-invasive MRI tracing. This may provide a basis for magnetically guided, genetically engineered cell therapeutics that can be monitored non-invasively with MRI.

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells

This manuscript describes the efficient, non-viral delivery of miR to endothelial cells by a PEI/MNP vector and their magnetization. Thus, in addition to genetic modification, this approach allows for magnetic cell guidance and MRI detectability. The technique can be used to improve the characteristics of therapeutic cell products.

To date, the available surgical and pharmacological treatments for cardiovascular diseases (CVD) are limited and often palliative. At the same time, gene ...

Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial Disease

The therapeutic goal for peripheral arterial disease and ischemic heart disease is to increase blood flow to ischemic areas caused by hemodynamic stenosis. Vascular surgery is a viable option in selected cases, but for patients without indications for surgery such as progression to rest pain, critical limb ischemia, or major disruptions to life or work, there are few possibilities for mitigating their disease. Cell therapy via monocyte-enhanced perfusion through the stimulation of collateral formation is one of a few non-invasive options.
Our group examines arteriogenesis after monocyte transplantation into mice using the hindlimb ischemia model. Previously, we have demonstrated improvement in hindlimb perfusion using tetanus-stimulated syngeneic monocyte transplantation. In addition to the effects on the collateral formation, tumor growth could be affected by this therapy as well. To investigate these effects, we use a basement membrane-like matrix mouse model by injecting the extracellular matrix of the Engelbreth-Holm-Swarm sarcoma into the flank of the mouse, after occlusion of the femoral artery.
After the artificial tumor studies, we use intravital microscopy to study in vivo tumor-angiogenesis and monocyte homing within collateral arteries. Previous studies have described the histological examination of animal models, which presupposes subsequent analysis to post-mortem artifacts. Our approach visualizes monocyte homing to areas of collateralization in real time sequences, is easy to perform, and investigates the process of arteriogenesis and tumor angiogenesis in vivo.

Monocytes are important mediators of arteriogenesis in the context of peripheral arterial disease. Using a basement membrane-like matrix and intravital microscopy, this protocol investigates monocyte homing and tumor-related angiogenesis after monocyte injection in the femoral artery ligation murine model.

The therapeutic goal for peripheral arterial disease and ischemic heart disease is to increase blood flow to ischemic areas caused by hemodynamic ...

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Occlusive arterial thrombosis leading to cerebral ischemic stroke and myocardial infarction contributes to ~13 million deaths every year globally. Here, we have translated a vascular injury model from a small animal into a large animal (canine), with slight modifications that can be used for pre-clinical screening of prophylactic and thrombolytic agents. In addition to the surgical methods, the modified protocol describes the step-by-step methods to assess carotid artery canalization by angiography, detailed instructions to process both the brain and carotid artery for histological analysis to verify carotid canalization and cerebral hemorrhage, and specific parameters to complete an assessment of downstream thromboembolic events by utilizing magnetic resonance imaging (MRI). In addition, specific procedural changes from the previously well-established small animal model necessary to translate into a large animal (canine) vascular injury are discussed.

Here, we present the modifications necessary to a well characterized and commonly used small animal ferric chloride-induced (FeCl3) carotid artery injury model for use in a large animal vascular injury model. The resulting model can be utilized for pre-clinical trial assessment of both prophylactic and thrombolytic pharmacological and mechanical interventions.

Occlusive arterial thrombosis leading to cerebral ischemic stroke and myocardial infarction contributes to ~13 million deaths every year globally. Here, ...

Immunofluorescence Labelling of Human and Murine Neutrophil Extracellular Traps in Paraffin-Embedded Tissue

Neutrophil granulocytes, also called polymorphonuclear leukocytes (PMN) due to their lobulated nucleus, are the most abundant type of leukocytes. They mature in the bone marrow and are released into the peripheral blood, where they circulate for about 6&#8722;8 h; however, in tissue, they can survive for days. By diapedesis through the endothelium, they leave the blood stream, enter tissues, and migrate towards the site of an infection following chemotactic gradients.&#160;Neutrophils can combat invading microorganisms by phagocytosis,&#160;degranulation, and generation of neutrophil extracellular traps (NETs). This protocol will help to detect NETs in paraffin-embedded tissue. NETs are the result of a process called NETosis, which leads to the release of nuclear, granular, and cytoplasmic components either from living (vital NETosis) or dying (suicidal NETosis) neutrophils. In vitro, NETs form cloud-like structures, which occupy a space several times larger than that of the cells from which they descended. The backbone of NETs is chromatin, to which a selection of proteins and peptides originating from granules and cytoplasm are bound. Thereby, a high local concentration of toxic compounds is maintained so that NETs can capture and inactivate a variety of pathogens including bacteria, fungi, viruses, and parasites, while diffusion of the highly active NET components leading to damage in neighboring tissue is limited. Nevertheless, in recent years it has become apparent that NETs, if generated in abundance or cleared insufficiently, do have pathological potential ranging from autoimmune diseases to cancer. Thus, detection of NETs in tissue samples may have diagnostic significance, and the detection of NETs in diseased tissue can influence the treatment of patients. Since paraffin-embedded tissue samples are the standard specimen used for pathological analysis, it was sought to establish a protocol for fluorescent staining of NET components in paraffin-embedded tissue using commercially available antibodies.

Neutrophil extracellular traps (NETs) are three-dimensional structures generated by stimulated neutrophil granulocytes. It has become clear in recent years that NETs are involved in a wide variety of diseases. Detection of NETs in tissue may have diagnostic relevance, so standardized protocols for labelling NET components are required.

Neutrophil granulocytes, also called polymorphonuclear leukocytes (PMN) due to their lobulated nucleus, are the most abundant type of leukocytes. They ...